299 related articles for article (PubMed ID: 31006081)
1. Lipopolysaccharide in systemic circulation induces activation of inflammatory response and oxidative stress in cardiorenal syndrome type 1.
Virzì GM; Breglia A; Castellani C; Ankawi G; Bolin C; de Cal M; Cianci V; Angelini A; Vescovo G; Ronco C
J Nephrol; 2019 Oct; 32(5):803-810. PubMed ID: 31006081
[TBL] [Abstract][Full Text] [Related]
2. Levels of Proinflammatory Cytokines, Oxidative Stress, and Tissue Damage Markers in Patients with Acute Heart Failure with and without Cardiorenal Syndrome Type 1.
Virzì GM; Breglia A; Brocca A; de Cal M; Bolin C; Vescovo G; Ronco C
Cardiorenal Med; 2018; 8(4):321-331. PubMed ID: 30205401
[TBL] [Abstract][Full Text] [Related]
3. Plasma Lipopolysaccharide Concentrations in Cardiorenal Syndrome Type 1.
Virzì GM; Breglia A; Ankawi G; Bolin C; de Cal M; Cianci V; Vescovo G; Ronco C
Cardiorenal Med; 2019; 9(5):308-315. PubMed ID: 31238313
[TBL] [Abstract][Full Text] [Related]
4. [Type 1 cardiorenal syndrome and its possible pathophysiological mechanisms].
Virzi' GM; de Cal M; Cruz DN; Bolin C; Vescovo G; Ronco C
G Ital Nefrol; 2012; 29(6):690-8. PubMed ID: 23229667
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress: dual pathway induction in cardiorenal syndrome type 1 pathogenesis.
Virzì GM; Clementi A; de Cal M; Brocca A; Day S; Pastori S; Bolin C; Vescovo G; Ronco C
Oxid Med Cell Longev; 2015; 2015():391790. PubMed ID: 25821554
[TBL] [Abstract][Full Text] [Related]
6. The Role of Cell-Free Plasma DNA in Patients with Cardiorenal Syndrome Type 1.
Virzì GM; Clementi A; Milan Manani S; Castellani C; Battaglia GG; Angelini A; Vescovo G; Ronco C
Cardiorenal Med; 2021; 11(5-6):218-225. PubMed ID: 34518452
[TBL] [Abstract][Full Text] [Related]
7. Determinants of Monocyte Apoptosis in Cardiorenal Syndrome Type 1.
Breglia A; Virzì GM; Pastori S; Brocca A; de Cal M; Bolin C; Vescovo G; Ronco C
Cardiorenal Med; 2018; 8(3):208-216. PubMed ID: 29847820
[TBL] [Abstract][Full Text] [Related]
8. Qiliqiangxin Protects against Renal Injury in Rat with Cardiorenal Syndrome Type I through Regulating the Inflammatory and Oxidative Stress Signaling.
Duan X; Yan F; Hu H; Liu H; Wu Q; Sun S; Ming X; Bu X; He Y; Zhu H
Biol Pharm Bull; 2018; 41(8):1178-1185. PubMed ID: 30068867
[TBL] [Abstract][Full Text] [Related]
9. Is circulating endotoxin the trigger for the systemic inflammatory response syndrome seen after injury?
Kelly JL; O'Sullivan C; O'Riordain M; O'Riordain D; Lyons A; Doherty J; Mannick JA; Rodrick ML
Ann Surg; 1997 May; 225(5):530-41; discussion 541-3. PubMed ID: 9193181
[TBL] [Abstract][Full Text] [Related]
10. Acute coronary syndrome and acute kidney injury: role of inflammation in worsening renal function.
Ortega-Hernández J; Springall R; Sánchez-Muñoz F; Arana-Martinez JC; González-Pacheco H; Bojalil R
BMC Cardiovasc Disord; 2017 Jul; 17(1):202. PubMed ID: 28747177
[TBL] [Abstract][Full Text] [Related]
11. Catalytic iron mediated renal stress responses during experimental cardiorenal syndrome 1 ("CRS-1").
Johnson AC; Zager RA
Transl Res; 2021 Nov; 237():53-62. PubMed ID: 34217897
[TBL] [Abstract][Full Text] [Related]
12. Systemic inflammation in acute cardiorenal syndrome: an observational pilot study.
Linhart C; Ulrich C; Greinert D; Dambeck S; Wienke A; Girndt M; Pliquett RU
ESC Heart Fail; 2018 Oct; 5(5):920-930. PubMed ID: 30015388
[TBL] [Abstract][Full Text] [Related]
13. Pro-Apoptotic Effects of Plasma from Patients with Cardiorenal Syndrome on Human Tubular Cells.
Virzì GM; de Cal M; Day S; Brocca A; Cruz DN; Castellani C; Cantaluppi V; Bolin C; Fedrigo M; Thiene G; Valente M; Angelini A; Vescovo G; Ronco C
Am J Nephrol; 2015; 41(6):474-84. PubMed ID: 26228789
[TBL] [Abstract][Full Text] [Related]
14. Recombinant
Liu X; Niu Y; Zhang X; Zhang Y; Yu Y; Huang J; Li J; Yu C
Anal Cell Pathol (Amst); 2019; 2019():5853426. PubMed ID: 31309036
[TBL] [Abstract][Full Text] [Related]
15. Cardiorenal syndrome type 1: a defective regulation of monocyte apoptosis induced by proinflammatory and proapoptotic factors.
Pastori S; Virzì GM; Brocca A; de Cal M; Clementi A; Vescovo G; Ronco C
Cardiorenal Med; 2015 Apr; 5(2):105-15. PubMed ID: 25999959
[TBL] [Abstract][Full Text] [Related]
16. Cystatin C, NT-proBNP, and inflammatory markers in acute heart failure: insights into the cardiorenal syndrome.
Lassus JP; Harjola VP; Peuhkurinen K; Sund R; Mebazaa A; Siirilä-Waris K; Miettinen K; Punnonen KR; Melin J; Pulkki K; Nieminen MS;
Biomarkers; 2011 Jun; 16(4):302-10. PubMed ID: 21417622
[TBL] [Abstract][Full Text] [Related]
17. Cardiorenal Syndrome Type 5 in Sepsis: Role of Endotoxin in Cell Death Pathways and Inflammation.
Virzì GM; Clementi A; Brocca A; de Cal M; Marcante S; Ronco C
Kidney Blood Press Res; 2016; 41(6):1008-1015. PubMed ID: 28006779
[TBL] [Abstract][Full Text] [Related]
18. Changes of thioredoxin, oxidative stress markers, inflammation and muscle/renal damage following intensive endurance exercise.
Sugama K; Suzuki K; Yoshitani K; Shiraishi K; Miura S; Yoshioka H; Mori Y; Kometani T
Exerc Immunol Rev; 2015; 21():130-42. PubMed ID: 25826051
[TBL] [Abstract][Full Text] [Related]
19. The inflammatory response in blood and in remote organs following acute kidney injury.
Brøchner AC; Dagnaes-Hansen F; Højberg-Holm J; Toft P
APMIS; 2014 May; 122(5):399-404. PubMed ID: 24033773
[TBL] [Abstract][Full Text] [Related]
20. Cardiorenal Syndrome Type 1 May Be Immunologically Mediated: A Pilot Evaluation of Monocyte Apoptosis.
Virzì GM; Torregrossa R; Cruz DN; Chionh CY; de Cal M; Soni SS; Dominici M; Vescovo G; Rosner MH; Ronco C
Cardiorenal Med; 2012 Feb; 2(1):33-42. PubMed ID: 22493601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
